Amarin Corp Plc\Uk financial data

Symbol
AMRN on Nasdaq
Industry
Pharmaceutical Preparations
Location
Spaces South Docklands, Block C, 77 Sir John Rogerson's Quay, Dublin 2, Ireland
State of incorporation
United Kingdom
Fiscal year end
December 31
Former names
AMARIN PHARMACEUTICALS PLC (to 7/13/2000), ETHICAL HOLDINGS PLC (to 1/28/1998)
Latest financial report
10-Q - Q2 2024 - Jul 31, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 289 % +10.9%
Quick Ratio 103 % +20%
Debt-to-equity 48 % -4.74%
Return On Equity -6.09 % +7.17%
Return On Assets -4.11 % +5.74%

Shares

Label TTM Value / Value Unit Change %
Common Stock, Shares, Outstanding 411M shares +0.73%
Entity Public Float 485M USD -32.8%
Common Stock, Value, Issued 305M USD +1.04%
Weighted Average Number of Shares Outstanding, Basic 411M shares +0.74%
Weighted Average Number of Shares Outstanding, Diluted 411M shares +0.87%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 265M USD -23.5%
Research and Development Expense 21.2M USD -4.87%
Operating Income (Loss) -40.4M USD +27.9%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -27M USD +37.3%
Income Tax Expense (Benefit) 6.5M USD
Net Income (Loss) Attributable to Parent -33.5M USD +12.5%
Earnings Per Share, Basic -0.09 USD/shares -12.5%
Earnings Per Share, Diluted -0.09 USD/shares -12.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 216M USD -7.33%
Accounts Receivable, after Allowance for Credit Loss, Current 124M USD +0.78%
Inventory, Net 239M USD +5.46%
Assets, Current 702M USD -0.66%
Property, Plant and Equipment, Net 49K USD -72.6%
Operating Lease, Right-of-Use Asset 7.54M USD -16%
Other Assets, Noncurrent 1.29M USD -19.8%
Assets 800M USD -7%
Accounts Payable, Current 54.4M USD +0.14%
Employee-related Liabilities, Current 18.9M USD -6.7%
Contract with Customer, Liability, Current 2.34M USD +6.46%
Liabilities, Current 231M USD -14.9%
Contract with Customer, Liability, Noncurrent 2.11M USD -83.4%
Operating Lease, Liability, Noncurrent 8.1M USD -14.5%
Other Liabilities, Noncurrent 9.34M USD +30.5%
Liabilities 248M USD -14.8%
Retained Earnings (Accumulated Deficit) -1.59B USD -2.15%
Stockholders' Equity Attributable to Parent 552M USD -3.03%
Liabilities and Equity 800M USD -7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -12.6M USD -79.8%
Net Cash Provided by (Used in) Financing Activities -1.43M USD -492%
Net Cash Provided by (Used in) Investing Activities 28.7M USD
Common Stock, Shares, Issued 422M shares +1.12%
Common Stock, Par or Stated Value Per Share 0.5 GBP/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 14.7M USD
Deferred Tax Assets, Valuation Allowance 172M USD +3.88%
Deferred Tax Assets, Gross 176M USD +3.52%
Operating Lease, Liability 9.7M USD -14.9%
Lessee, Operating Lease, Liability, to be Paid 13.2M USD -17.7%
Property, Plant and Equipment, Gross 1.49M USD -55.4%
Operating Lease, Liability, Current 1.62M USD -15.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.19M USD -0.36%
Lessee, Operating Lease, Liability, to be Paid, Year One 2.36M USD -18.4%
Operating Lease, Weighted Average Discount Rate, Percent 0.12 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 3.48M USD -25.1%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.97M USD -8.86%
Deferred Tax Assets, Operating Loss Carryforwards 154M USD +12.6%
Unrecognized Tax Benefits 18.7M USD -0.31%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.98M USD +0.76%
Additional Paid in Capital 1.91B USD +0.79%
Amortization of Intangible Assets 729K USD +3.85%
Deferred Tax Assets, Net of Valuation Allowance 4.52M USD -8.54%